BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA

Core Viewpoint - BioMarin Pharmaceutical Inc. will present at the 44th Annual J.P. Morgan Conference on January 12, 2026, where preliminary financial results for the year ended December 31, 2025, will be announced [1]. Company Overview - BioMarin is a leading global biotechnology company focused on rare diseases, with a commitment to developing medicines for genetically defined conditions [3]. - Founded in 1997 and based in San Rafael, California, BioMarin has a strong track record of innovation, featuring eight commercial therapies and a robust clinical and preclinical pipeline [3]. - The company employs a unique approach to drug discovery and development, aiming to leverage genetic science to create impactful medicines for patients [3].